Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Provention Bio Inc (PRVB)

Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMED, PRVB, INFI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

GMED : 82.92 (-0.48%)
PRVB : 24.98 (+3.10%)
INFI : 0.0080 (-50.00%)
PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Provention Bio, Inc. (NasdaqGS: PRVB) to Sanofi...

PRVB : 24.98 (+3.10%)
SNY : 48.43 (-0.06%)
Is Sanofi Stock a Buy Now?

The pharma giant has outperformed the broader market over the past 12 months.

PRVB : 24.98 (+3.10%)
SNY : 48.43 (-0.06%)
Why Provention Bio Stock Skyrocketed 256% This Week

Provention Bio is currently a partner of Sanofi. It should soon become a part of the big French drugmaker.

PRVB : 24.98 (+3.10%)
SNY : 48.43 (-0.06%)
Why Shares of MacroGenics Climbed Thursday

The cancer-focused biotech delivered a strong earnings report.

INCY : 72.11 (-5.02%)
PRVB : 24.98 (+3.10%)
MGNX : 3.48 (-0.57%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Provention Bio, Inc. - PRVB

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

PRVB : 24.98 (+3.10%)
PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Provention Bio, Inc. (NasdaqGS: PRVB) to Sanofi...

PRVB : 24.98 (+3.10%)
SNY : 48.43 (-0.06%)
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners

On a volatile market day, companies are still looking for smart combinations.

COMP : 6.95 (-1.56%)
$NASX : 19,736.69 (-0.62%)
$DOWI : 44,401.93 (-0.54%)
$SPX : 6,052.85 (-0.61%)
PRVB : 24.98 (+3.10%)
SGEN : 228.74 (-0.07%)
SNY : 48.43 (-0.06%)
PFE : 26.10 (+1.44%)
KeyCorp, Philips 66 fall; Seagen, Insulet rise

Stocks that traded heavily or had substantial price changes Monday: KeyCorp, Philips 66 fall; Seagen, Insulet rise

ILMN : 147.53 (+4.56%)
PODD : 265.12 (-0.13%)
PFE : 26.10 (+1.44%)
SBNY : 1.5000 (-6.25%)
KEY : 18.54 (-1.75%)
SIVB : 106.04 (-60.41%)
XM : 18.14 (unch)
PRVB : 24.98 (+3.10%)
Sanofi (NASDAQ: SNY) Set to Acquire Provention Bio (NASDAQ: PRVB) for $2.9 Billion

Provention Bio, Inc. (NASDAQ: PRVB) is engaged as a commercial-stage biopharmaceutical company, which is focused on the research, development and

SNY : 48.43 (-0.06%)
PRVB : 24.98 (+3.10%)

Barchart Exclusives

1 Overlooked Dividend Stock to Buy This December
This dividend energy stock looks undervalued, according to one analyst. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar